Login to Your Account



Mayo clinician reports on patient death in oncolytic virus trial

By Cormac Sheridan
Staff Writer

Monday, July 6, 2015

DUBLIN – Further information on the first death of a cancer patient undergoing oncolytic viral therapy with a VSV strain engineered to express human interferon-β has emerged.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription